These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 17238810)

  • 1. Voriconazole and fungal keratitis: a report of two treatment failures.
    Giaconi JA; Marangon FB; Miller D; Alfonso EC
    J Ocul Pharmacol Ther; 2006 Dec; 22(6):437-9. PubMed ID: 17238810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical and oral voriconazole in the treatment of fungal keratitis.
    Bunya VY; Hammersmith KM; Rapuano CJ; Ayres BD; Cohen EJ
    Am J Ophthalmol; 2007 Jan; 143(1):151-3. PubMed ID: 17188052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of Fusarium keratitis with cornea transplantation and topical and systemic voriconazole.
    Klont RR; Eggink CA; Rijs AJ; Wesseling P; Verweij PE
    Clin Infect Dis; 2005 Jun; 40(12):e110-2. PubMed ID: 15909252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro investigations of fungal keratitis caused by Colletotrichum gloeosporioides.
    Mitani A; Shiraishi A; Uno T; Miyamoto H; Hara Y; Yamaguchi M; Ohashi Y
    J Ocul Pharmacol Ther; 2009 Dec; 25(6):563-5. PubMed ID: 20028265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting treatment outcomes with voriconazole in cases with fungal keratitis.
    Ramakrishnan T; Constantinou M; Jhanji V; Vajpayee RB
    Cornea; 2013 Apr; 32(4):445-9. PubMed ID: 22580440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of intrastromal voriconazole injection and topical voriconazole in the treatment of recalcitrant Fusarium keratitis.
    Siatiri H; Daneshgar F; Siatiri N; Khodabande A
    Cornea; 2011 Aug; 30(8):872-5. PubMed ID: 21448063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis.
    Thiel MA; Zinkernagel AS; Burhenne J; Kaufmann C; Haefeli WE
    Antimicrob Agents Chemother; 2007 Jan; 51(1):239-44. PubMed ID: 17060517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voriconazole versus natamycin as primary treatment in fungal corneal ulcers.
    Arora R; Gupta D; Goyal J; Kaur R
    Clin Exp Ophthalmol; 2011 Jul; 39(5):434-40. PubMed ID: 21105974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens.
    Marangon FB; Miller D; Giaconi JA; Alfonso EC
    Am J Ophthalmol; 2004 May; 137(5):820-5. PubMed ID: 15126145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful salvage treatment of Scedosporium apiospermum keratitis with topical voriconazole after failure of natamycin.
    Al-Badriyeh D; Leung L; Davies GE; Stewart K; Kong D
    Ann Pharmacother; 2009 Jun; 43(6):1139-42. PubMed ID: 19435962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical voriconazole as a novel treatment for fungal keratitis.
    Sponsel W; Chen N; Dang D; Paris G; Graybill J; Najvar LK; Zhou L; Lam KW; Glickman R; Scribbick F
    Antimicrob Agents Chemother; 2006 Jan; 50(1):262-8. PubMed ID: 16377696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of voriconazole in the management of post-penetrating keratoplasty Paecilomyces keratitis.
    Deng SX; Kamal KM; Hollander DA
    J Ocul Pharmacol Ther; 2009 Apr; 25(2):175-7. PubMed ID: 19284327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful use of topical voriconazole 1% alone as first-line antifungal therapy against Candida albicans keratitis.
    Al-Badriyeh D; Leung L; Davies GE; Stewart K; Kong D
    Ann Pharmacother; 2009 Dec; 43(12):2103-7. PubMed ID: 19861430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The successful medical treatment of a case of Paecilomyces lilacinus keratitis.
    Wu PC; Lai CH; Tan HY; Ma DH; Hsiao CH
    Cornea; 2010 Mar; 29(3):357-8. PubMed ID: 20098311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of voriconazole against corneal isolates of Scedosporium apiospermum.
    Shah KB; Wu TG; Wilhelmus KR; Jones DB
    Cornea; 2003 Jan; 22(1):33-6. PubMed ID: 12502945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole.
    Prajna NV; Krishnan T; Mascarenhas J; Rajaraman R; Prajna L; Srinivasan M; Raghavan A; Oldenburg CE; Ray KJ; Zegans ME; McLeod SD; Porco TC; Acharya NR; Lietman TM;
    JAMA Ophthalmol; 2013 Apr; 131(4):422-9. PubMed ID: 23710492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of tunnel fungal infection with voriconazole.
    Jhanji V; Sharma N; Mannan R; Titiyal JS; Vajpayee RB
    J Cataract Refract Surg; 2007 May; 33(5):915-7. PubMed ID: 17466872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of in vitro susceptibility of ocular Fusarium spp. isolates from keratitis cases and comparison of Clinical and Laboratory Standards Institute M38-A2 and E test methods.
    Iqbal NJ; Boey A; Park BJ; Brandt ME
    Diagn Microbiol Infect Dis; 2008 Nov; 62(3):348-50. PubMed ID: 18707841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal efficacy of voriconazole, itraconazole and amphotericin b in experimental fusarium solani keratitis.
    Yavas GF; Oztürk F; Küsbeci T; Cetinkaya Z; Ermis SS; Kiraz N; Inan UU
    Graefes Arch Clin Exp Ophthalmol; 2008 Feb; 246(2):275-9. PubMed ID: 17912543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of topical voriconazole in Alternaria keratitis].
    De-Domingo-Barón B; Rodríguez-Ares T; Touriño-Peralba R; Pardo-Sánchez F; Romero-Jung P; Barcia M
    Arch Soc Esp Oftalmol; 2008 Aug; 83(8):493-5. PubMed ID: 18661446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.